🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Thrombocytopenia Alloimmune

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia NCT06337474EARLY Phase 11 site📍 Changzhou Changzhou No.2 People's Hospital · Tests: anti-CD19 CAR NK cells (KN5501) A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) NCT06449651Phase 321 sites📍 Leuven📍 Recife📍 Rio de Janeiro Janssen Research & Development, LLC · Tests: Nipocalimab, Placebo A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) NCT06533098Phase 328 sites📍 Birmingham📍 Sacramento📍 Aurora Janssen Research & Development, LLC · Tests: Nipocalimab, Intravenous immunoglobulins (IVIG), Prednisone The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia NCT04598750n/a8 sites📍 Boston📍 Boston📍 Murray Karolinska Institutet
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy